JP2015517471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517471A5 JP2015517471A5 JP2015510577A JP2015510577A JP2015517471A5 JP 2015517471 A5 JP2015517471 A5 JP 2015517471A5 JP 2015510577 A JP2015510577 A JP 2015510577A JP 2015510577 A JP2015510577 A JP 2015510577A JP 2015517471 A5 JP2015517471 A5 JP 2015517471A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- antitumor agent
- inhibits
- antitumor
- angiogenin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002246 antineoplastic agent Substances 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 102100018024 ANG Human genes 0.000 claims 3
- 108010072788 angiogenin Proteins 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 206010061818 Disease progression Diseases 0.000 claims 1
- 230000036091 Metabolic activity Effects 0.000 claims 1
- 206010027476 Metastasis Diseases 0.000 claims 1
- 210000004080 Milk Anatomy 0.000 claims 1
- 206010061309 Neoplasm progression Diseases 0.000 claims 1
- 206010064390 Tumour invasion Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000000259 anti-tumor Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 230000005059 dormancy Effects 0.000 claims 1
- 230000002503 metabolic Effects 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000003223 protective agent Substances 0.000 claims 1
- -1 radiological therapy Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000004083 survival Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
Claims (8)
- アンギオゲニンを有効成分とする抗腫瘍剤。
- 抗腫瘍剤が、腫瘍体積の減少、腫瘍増殖の阻害又は遅延、腫瘍進行の阻害、腫瘍の代謝活性の変化、腫瘍の休眠の誘発、転移の阻害又は抑制、腫瘍浸潤の阻害又は抑制、腫瘍重量の減少、腫瘍血管新生の抑制、疾患進行までの時間(TDP)の改善、及び/又は生存率の向上を含む、請求項1に記載の抗腫瘍剤。
- アンギオゲニンを、アンギオゲニンを富化させたミルク抽出物として含有する、請求項1に記載の抗腫瘍剤。
- さらに化学療法剤、放射線療法、又はその両方を併用する請求項1〜3のいずれかに記載の抗腫瘍剤。
- さらに、化学保護剤を含有する請求項1〜4のいずれかに記載の抗腫瘍剤。
- 経口投与用抗腫瘍剤である請求項1〜5のいずれかに記載の抗腫瘍剤。
- 抗腫瘍栄養補助食品である請求項1〜6のいずれかに記載の抗腫瘍剤。
- アンギオゲニンと化学療法剤とを含む組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012901918 | 2012-05-10 | ||
AU2012901918A AU2012901918A0 (en) | 2012-05-10 | Methods for treating cancer | |
AU2013204740A AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
AU2013204740 | 2013-04-12 | ||
PCT/AU2013/000478 WO2013166555A1 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018023212A Division JP2018100288A (ja) | 2012-05-10 | 2018-02-13 | 癌治療方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015517471A JP2015517471A (ja) | 2015-06-22 |
JP2015517471A5 true JP2015517471A5 (ja) | 2016-06-30 |
Family
ID=49549993
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015510577A Pending JP2015517471A (ja) | 2012-05-10 | 2013-05-10 | 癌治療方法 |
JP2018023212A Pending JP2018100288A (ja) | 2012-05-10 | 2018-02-13 | 癌治療方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018023212A Pending JP2018100288A (ja) | 2012-05-10 | 2018-02-13 | 癌治療方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9839676B2 (ja) |
EP (1) | EP2846820A4 (ja) |
JP (2) | JP2015517471A (ja) |
CN (1) | CN104470533A (ja) |
AU (1) | AU2013204740C1 (ja) |
BR (1) | BR112014027967A2 (ja) |
CA (1) | CA2872850A1 (ja) |
NZ (1) | NZ631749A (ja) |
RU (1) | RU2014149807A (ja) |
WO (1) | WO2013166555A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101760758B1 (ko) | 2008-05-14 | 2017-07-24 | 애그리컬쳐 빅토리아 서비스 피티와이 엘티디 | 질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용 |
AU2013204740C1 (en) | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
RU2697480C2 (ru) * | 2014-03-06 | 2019-08-14 | Юниверсити Оф Саутерн Калифорния | Применение режима краткосрочного голодания в сочетании с ингибиторами киназ для усовершенствования традиционной химио-лекарственной эффективности и пригодности и обращения вспять побочных эффектов от киназ в нормальных клетках и тканях |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623509B1 (fr) | 1987-11-19 | 1990-04-20 | Centre Nat Rech Scient | Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments |
ATE129125T1 (de) | 1992-01-15 | 1995-11-15 | Campina Melkunie Bv | Verfahren zur isolierung von lactoferrin und lactoperoxidase aus milch und milchprodukten. |
DE69433870T2 (de) | 1993-03-18 | 2005-06-30 | Cytimmune Sciences, Inc. | Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren |
JP3112637B2 (ja) | 1994-09-30 | 2000-11-27 | 雪印乳業株式会社 | 骨強化剤 |
JP2974604B2 (ja) | 1996-01-23 | 1999-11-10 | 雪印乳業株式会社 | 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用 |
JP3929088B2 (ja) | 1996-06-20 | 2007-06-13 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
RU2110066C1 (ru) | 1996-12-27 | 1998-04-27 | Московский государственный университет прикладной биотехнологии | Способ количественного определения ангиогенина в биологическом сырье |
NL1005677C2 (nl) | 1997-03-27 | 1998-09-29 | Campina Melkunie Bv | Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan. |
KR100236977B1 (ko) | 1997-11-01 | 2000-01-15 | 윤재승 | 인간 상피세포 성장인자와 인간 안지오게닌의 융합독소단백질 및 그의 제조방법 |
WO1999058126A1 (en) | 1998-05-11 | 1999-11-18 | The Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
EP1203074A4 (en) | 1999-06-29 | 2003-09-10 | J Alexander Marchosky | BONE FORMATION AND STRENGTHENING COMPOSITIONS AND METHOD |
EP1217070A1 (en) | 2000-12-22 | 2002-06-26 | CellGenix Technologie Transfer GmbH | Selective cytotoxic fusion proteins |
TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
RU2204262C2 (ru) | 2001-07-06 | 2003-05-20 | Московский государственный университет прикладной биотехнологии | Способ получения биологически активного белкового концентрата, обогащенного панкреатической рибонуклеазой а, ангиогенином и лизоцимом, из молочного ультрафильтрата |
CN1161467C (zh) * | 2001-07-09 | 2004-08-11 | 中国人民解放军军事医学科学院生物工程研究所 | 抗肿瘤作用的融合蛋白及该蛋白的应用 |
JP4291967B2 (ja) | 2001-11-08 | 2009-07-08 | 雪印乳業株式会社 | 皮膚コラーゲン産生促進剤 |
EP1529054A4 (en) | 2001-11-27 | 2005-12-28 | Univ Washington | THERAPEUTIC PROTEIN AND TREATMENTS |
MXPA05006521A (es) | 2002-12-20 | 2005-08-26 | Amgen Inc | Agentes de enlace que inhiben miostatina. |
JP4698935B2 (ja) | 2003-05-07 | 2011-06-08 | 雪印乳業株式会社 | 皮膚コラーゲン産生促進剤 |
WO2004106491A2 (en) | 2003-05-22 | 2004-12-09 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Angiogenin-based hiv-1 therapies |
US8114969B2 (en) * | 2003-10-01 | 2012-02-14 | Isis Innovation, Ltd. | Immunotoxin derived from a recombinant human autoantibody and method of using thereof |
CA2542494A1 (en) | 2003-10-15 | 2005-05-06 | Bayer Healthcare Ag | Tetrahydro-naphthalene and urea derivatives |
WO2005072764A2 (en) | 2004-01-16 | 2005-08-11 | Novocell, Inc. | Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
US8147561B2 (en) | 2004-02-26 | 2012-04-03 | Endosphere, Inc. | Methods and devices to curb appetite and/or reduce food intake |
JP2007526337A (ja) | 2004-03-02 | 2007-09-13 | アクセルロン ファーマ インコーポレーテッド | Alk7およびミオスタチン阻害剤ならびにその使用 |
BRPI0512394A (pt) * | 2004-06-22 | 2008-03-11 | Pro Pharmaceuticals Inc | composições e métodos para co-distribuição de fármacos anticáncer, fármacos antiangiogênicos e um polissacarìdeo |
GB0425625D0 (en) | 2004-11-22 | 2004-12-22 | Royal College Of Surgeons Ie | Treatment of disease |
US20060251739A1 (en) | 2005-05-04 | 2006-11-09 | National Yang-Ming University | Composition and method for treating autoimmune disease and mucosal disorder |
EP1917022A2 (en) | 2005-07-26 | 2008-05-07 | Kirin Pharma Kabushiki Kaisha | Anti-tumor agents comprising r-spondins |
WO2007023479A2 (en) | 2005-08-23 | 2007-03-01 | Royal College Of Surgeons In Ireland | Treatment of central nervous system injury |
EP3811965A1 (en) | 2005-11-23 | 2021-04-28 | Acceleron Pharma, Inc. | Activin-actriia antagonists in use for promoting bone growth |
CA2633131A1 (en) | 2005-12-21 | 2007-06-28 | Viventia Biotech Inc. | Novel cancer-associated antigen |
AR060632A1 (es) | 2006-04-26 | 2008-07-02 | Genentech Inc | Compuestos inhibidores de fosfoinositida 3- quinasa y metodos de uso |
US8021659B2 (en) | 2006-04-28 | 2011-09-20 | Naidu Lp | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
US20070275036A1 (en) | 2006-05-18 | 2007-11-29 | Celldyne Biopharma, Llc | Avian follistatin product |
JP2009543868A (ja) | 2006-07-17 | 2009-12-10 | クインテセンス バイオサイエンシーズ インコーポレーティッド | 癌治療に関する方法および組成物 |
WO2008055310A1 (en) | 2006-11-10 | 2008-05-15 | Murray Goulburn Co-Operative Co. Limited | Process for the preparation of angiogenin |
US7601689B2 (en) | 2007-04-12 | 2009-10-13 | Naidu Lp | Angiogenin complexes (ANGex) and uses thereof |
WO2009039981A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
AU2013204721B2 (en) | 2008-05-14 | 2016-08-18 | Agriculture Victoria Services Pty Ltd | Methods for treating cachexia |
RU2010150934A (ru) | 2008-05-14 | 2012-06-20 | Эгрикалчер Виктория Сервисиз Пти Лтд (Au) | Пероральный препарат |
CA2723994C (en) | 2008-05-14 | 2018-05-01 | Agriculture Victoria Services Pty Ltd | Angiogenin-enriched milk fractions |
KR101760758B1 (ko) * | 2008-05-14 | 2017-07-24 | 애그리컬쳐 빅토리아 서비스 피티와이 엘티디 | 질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용 |
CA2818467A1 (en) | 2009-11-18 | 2011-05-26 | Murray Goulburn Co-Operative Co. Limited | Recombinant microorganisms |
EP2501411A4 (en) | 2009-11-18 | 2013-07-03 | Murray Goulburn Coop Co Ltd | PROCESS FOR IMPROVED ORAL ADMINISTRATION |
US20120331575A1 (en) | 2009-11-18 | 2012-12-27 | Agriculture Victoria Services Pty Ltd | Transgenic non-human animals |
US9855320B2 (en) | 2011-10-06 | 2018-01-02 | Chung-Ang University Industry-Academic Cooperation Foundation | Angiogenin for treatment of glaucoma |
AU2013204740C1 (en) | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
-
2013
- 2013-04-12 AU AU2013204740A patent/AU2013204740C1/en not_active Ceased
- 2013-05-10 EP EP13787726.2A patent/EP2846820A4/en not_active Withdrawn
- 2013-05-10 WO PCT/AU2013/000478 patent/WO2013166555A1/en active Application Filing
- 2013-05-10 NZ NZ631749A patent/NZ631749A/en not_active IP Right Cessation
- 2013-05-10 US US14/399,852 patent/US9839676B2/en not_active Expired - Fee Related
- 2013-05-10 RU RU2014149807A patent/RU2014149807A/ru unknown
- 2013-05-10 BR BR112014027967A patent/BR112014027967A2/pt not_active IP Right Cessation
- 2013-05-10 JP JP2015510577A patent/JP2015517471A/ja active Pending
- 2013-05-10 CA CA2872850A patent/CA2872850A1/en not_active Abandoned
- 2013-05-10 CN CN201380037180.4A patent/CN104470533A/zh active Pending
-
2018
- 2018-02-13 JP JP2018023212A patent/JP2018100288A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015078230A5 (ja) | ||
PH12015500686A1 (en) | Nicotine composition | |
JP2011079858A5 (ja) | ||
JP2012255026A5 (ja) | ||
MX2015013845A (es) | Polvos secos de tiotropio. | |
JP2015517471A5 (ja) | ||
JP2014506233A5 (ja) | ||
RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
JP2015507020A5 (ja) | ||
PH12014502619A1 (en) | Novel dosage and formulation | |
WO2012151279A3 (en) | Induction of il-12 using immunotherapy | |
JP2015522025A5 (ja) | ||
ZA201404068B (en) | The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents | |
RU2014149807A (ru) | Способы лечения злокачественных новообразований с помощью ангиогенина или агониста ангиогенина | |
JP2016528283A5 (ja) | ||
JP2015120650A5 (ja) | ||
Campanella et al. | A novel copper compound, CuNV110, induces apoptosis in tumor cells by dissociation of the Hsp60-pro-caspase 3 complex | |
LV15003A (lv) | Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei | |
TH87455B (th) | ผงชนิดแตกตัวในปากซึ่งประกอบรวมด้วยไซโลสทาซอล | |
WO2020018049A3 (en) | Lipid nanoparticles loaded with ceranib-2 as anticancer agents | |
JP2014074055A5 (ja) | ||
El-Aarag | Lung Disorders & Therapeutics | |
Sakurai et al. | Evaluation of Superselective Intra-Arterial Chemotherapy for Laryngeal Cancer | |
Ghosh et al. | Corticosteroid or Pentoxifylline for treatment of severe alcoholic hepatitis: Experience from a tertiary care center in India | |
姚忆蓉 | Association for Molecular Pathology v. Myriad Genetics, Inc. |